Fact Sheet for Healthcare Providers: Sofia 2 SARS Antigen FIA – Quidel Corporation

Source: U.S. Food and Drug Administration (FDA). Published: 5/8/2020. This three-page fact sheets informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Sofia 2 SARS Antigen FIA test, which received an Emergency Use Authorization from the Food and Drug Administration on May 8, 2020. The Sofia 2 SARS Antigen FIA test is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news